Longitudinal pattern of depressive symptoms around natural menopause

JAMA Psychiatry

Volumn 71, Issue 1, 2014, Pages 36-43

  Freeman, Ellen W ^a   Sammel, Mary D ^a   Boorman, David W ^a   Zhang, Rongmei ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; FOLLITROPIN;

ADULT; ARTICLE; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; DEPRESSION; FEMALE; HORMONE BLOOD LEVEL; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MENOPAUSE; OUTCOME ASSESSMENT; PREVALENCE; RISK ASSESSMENT; SCORING SYSTEM; SYMPTOM;

EID: 84892720803     PISSN: 2168622X     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapsychiatry.2013.2819     Document Type: Article

References (27)

1. Freeman EW, Sammel MD, Liu L, Gracia CR, Nelson DB, Hollander L. Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch Gen Psychiatry. 2004;61(1):62-70. (Pubitemid 38044642)
2. Cohen LS, Soares CN, Vitonis AF, Otto MW, Harlow BL. Risk for new onset of depression during the menopausal transition: the Harvard Study of Moods and Cycles. Arch Gen Psychiatry. 2006;63(4):385-390.
3. Freeman EW, Sammel MD, Lin H, Nelson DB. Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry. 2006;63(4): 375-382.
4. Bromberger JT, Schott LL, Kravitz HM, et al. Longitudinal change in reproductive hormones and depressive symptoms across the menopausal transition: results from the Study of Women's Health Across the Nation (SWAN). Arch Gen Psychiatry. 2010;67(6):598-607.
5. Steinberg EM, Rubinow DR, Bartko JJ, et al. A cross-sectional evaluation of perimenopausal depression. J Clin Psychiatry. 2008;69(6):973-980. (Pubitemid 351944953)
6. Schmidt PJ, Haq N, Rubinow DR. A longitudinal evaluation of the relationship between reproductive status and mood in perimenopausal women. Am J Psychiatry. 2004;161(12):2238-2244. (Pubitemid 39587289)
7. Colangelo LA, Craft LL, Ouyang P, et al. Association of sex hormones and sex hormone-binding globulin with depressive symptoms in postmenopausal women: the Multiethnic Study of Atherosclerosis. Menopause. 2012;19(8):877-885.
8. Lopez AD, Murray CC. The global burden of disease, 1990-2020. Nat Med. 1998;4(11):1241-1243. (Pubitemid 28512100)
9. Schnatz PF, Nudy M, Shively CA, Powell A, O'Sullivan DM. A prospective analysis of the association between cardiovascular disease and depression in middle-aged women. Menopause. 2011;18(10):1096-1100.
10. Goldbacher EM, Bromberger J, Matthews KA. Lifetime history of major depression predicts the development of themetabolic syndrome in middle-aged women. Psychosom Med. 2009;71(3):266-272.
11. Cizza G, Primma S, Csako G. Depression as a risk factor for osteoporosis. Trends Endocrinol Metab. 2009;20(8):367-373.
12. Yirmiya R, Bab I. Major depression is a risk factor for low bone mineral density: ameta-analysis. Biol Psychiatry. 2009;66(5):423-432.
13. Bromberger JT, Kravitz HM, Chang YF, Cyranowski JM, Brown C, Matthews KA. Major depression during and after the menopausal transition: Study of Women's Health Across the Nation (SWAN). Psychol Med. 2011;41(9):1879-1888.
14. Woods NF, Smith-DiJulio K, Percival DB, Tao EY, Mariella A, Mitchell S. Depressed mood during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study. Menopause. 2008;15(2):223-232. (Pubitemid 351354981)
15. Dennerstein L, Guthrie JR, Clark M, Lehert P, Henderson VW. A population-based study of depressed mood in middle-aged, Australian-born women. Menopause. 2004;11(5):563-568. (Pubitemid 40362156)
16. Gibson CJ, Joffe H, Bromberger JT, et al. Mood symptoms after natural menopause and hysterectomy with and without bilateral oophorectomy among women in midlife. Obstet Gynecol. 2012;119(5):935-941.
17. Quick Stats: prevalence of current depression among persons aged 12 years, by age group and sex-United States, National Health and Nutrition Examination Survey, 2007-2010. MMWR Morb Mortal Wkly Rep. 2012;60(51):1747.
18. Hollander LE, Freeman EW, Sammel MD, Berlin JA, Grisso JA, Battistini M. Sleep quality, estradiol levels, and behavioral factors in late reproductive age women. Obstet Gynecol. 2001;98(3):391-397.
19. Lewinsohn PM, Seeley JR, Roberts RE, Allen NB. Center for Epidemiologic Studies Depression Scale (CES-D) as a screening instrument for depression among community-residing older adults. Psychol Aging. 1997;12(2):277-287. (Pubitemid 27250179)
20. Harlow BL, Cohen LS, Otto MW, Spiegelman D, Cramer DW. Prevalence and predictors of depressive symptoms in older premenopausal women: the Harvard Study of Moods and Cycles. Arch Gen Psychiatry. 1999;56(5):418-424. (Pubitemid 29215430)
21. Spitzer RL, Williams JB, Kroenke K, et al. Utility of a new procedure for diagnosing mental disorders in primary care: the PRIME-MD 1000 study. JAMA. 1994;272(22):1749-1756. (Pubitemid 24372002)
22. Harlow SD, Gass M, Hall JE, et al; STRAW10 Collaborative Group. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. Menopause. 2012;19(4): 387-395.
23. Liang KY, Leger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73(1):13-22.
24. Zheng H, Sowers M, Randolph JF, Harlow SD. An integrated quantitativemethodology to longitudinally characterize complex dynamic processes associated with ovarian aging and the menopausal transition. J Syst Cybern Inform. 2011;9(3):15-23.
25. Lutwak N, Dill C. The importance of screening and treating depression in all women. JWomens Health (Larchmt). 2012;21(12):1302.
26. Pinkerton JV, Stovall DW, Kightlinger RS. Advances in the treatment of menopausal symptoms. Womens Health (Lond Engl). 2009;5(4):361-384.
27. North American Menopause Society. The 2012 hormone therapy position statement of: The North American Menopause Society. Menopause. 2012;19(3):257-271.